drugset / Trial / NCT01395329

Nebivolol and the Endothelin (ET)-1 System

NCT01395329

RandomizedParallel-groupTriple-blindOther

Summary

The investigators hypothesize that nebivolol will reduce ET-1-mediated vasoconstrictor tone in adult humans with elevated blood pressure to a greater extent than either metoprolol or placebo.

Timeline

Start
2011-05
Primary completion
2016-11
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metoprolol Other / unclassified 100 mg Oral
Comparator Nebivolol Other / unclassified 5 mg Oral

Indications